A common variant that alters SUN1 degradation associates with hepatic steatosis and metabolic traits in multiple cohorts
{{output}}
Background & aims: Non-alcoholic fatty liver disease (NAFLD), and its progressive form steatohepatitis (NASH), represent a genetically and phenotypically diverse entity for which there is no approved therapy, making it imperative... ...
